leila farahmand
leila farahmand
Recombinant Proteins Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR
No verified email
Cited by
Cited by
Breast cancer: Biology, biomarkers, and treatments
K Barzaman, J Karami, Z Zarei, A Hosseinzadeh, MH Kazemi, ...
International immunopharmacology 84, 106535, 2020
Potential role of interferons in treating COVID-19 patients
MH Abdolvahab, S Moradi-Kalbolandi, M Zarei, D Bose, K Majidzadeh-A, ...
International immunopharmacology 90, 107171, 2021
Breast cancer immunotherapy: Current and novel approaches
K Barzaman, S Moradi-Kalbolandi, A Hosseinzadeh, MH Kazemi, ...
International immunopharmacology 98, 107886, 2021
Self-filling microwell arrays (SFMAs) for tumor spheroid formation
A Seyfoori, E Samiei, N Jalili, B Godau, M Rahmanian, L Farahmand, ...
Lab on a Chip 18 (22), 3516-3528, 2018
Triple-negative breast cancer: understanding Wnt signaling in drug resistance
P Merikhian, MR Eisavand, L Farahmand
Cancer cell international 21 (1), 419, 2021
Stimuli-responsive mesoporous silica NPs as non-viral dual siRNA/chemotherapy carriers for triple negative breast cancer
B Darvishi, L Farahmand, K Majidzadeh-A
Molecular Therapy-Nucleic Acids 7, 164-180, 2017
MUC1 induces tamoxifen resistance in estrogen receptor-positive breast cancer
P Merikhian, R Ghadirian, L Farahmand, S Mansouri, K Majidzadeh-A
Expert Review of Anticancer Therapy 17 (7), 607-613, 2017
NF-κB as the main node of resistance to receptor tyrosine kinase inhibitors in triple-negative breast cancer
B Darvishi, L Farahmand, Z Eslami-S, K Majidzadeh-A
Tumor Biology 39 (6), 1010428317706919, 2017
The role of activated leukocyte cell adhesion molecule (ALCAM) in cancer progression, invasion, metastasis and recurrence: A novel cancer stem cell marker and tumor-specific …
B Darvishi, S Boroumandieh, K Majidzadeh-A, M Salehi, F Jafari, ...
Experimental and molecular pathology 115, 104443, 2020
Significant role of MUC1 in development of resistance to currently existing anti-cancer therapeutic agents
L Farahmand, P Merikhian, N Jalili, B Darvishi, K Majidzadeh-A
Current Cancer Drug Targets 18 (8), 737-748, 2018
Monoclonal antibody-based therapeutics, targeting the epidermal growth factor receptor family: from herceptin to Pan HER
S Moradi-Kalbolandi, A Hosseinzade, M Salehi, P Merikhian, ...
Journal of Pharmacy and Pharmacology 70 (7), 841-854, 2018
Interferons: Role in cancer therapy
MH Abdolvahab, B Darvishi, M Zarei, K Majidzadeh-A, L Farahmand
Immunotherapy 12 (11), 833-855, 2020
Challenges facing antiangiogenesis therapy: the significant role of hypoxia‐inducible factor and MET in development of resistance to anti‐vascular endothelial growth factor …
A Mahdi, B Darvishi, K Majidzadeh‐A, M Salehi, L Farahmand
Journal of Cellular Physiology 234 (5), 5655-5663, 2019
Naturally occurring compounds acting as potent anti‐metastatic agents and their suppressing effects on Hedgehog and WNT/β‐catenin signalling pathways
L Farahmand, B Darvishi, K Majidzadeh‐A, A Madjid Ansari
Cell Proliferation 50 (1), e12299, 2017
Crosstalk between MUC1 and VEGF in angiogenesis and metastasis: a review highlighting roles of the MUC1 with an emphasis on metastatic and angiogenic signaling
F Khodabakhsh, P Merikhian, MR Eisavand, L Farahmand
Cancer Cell International 21 (1), 200, 2021
The antiproliferative effects of cold atmospheric plasma‐activated media on different cancer cell lines, the implication of ozone as a possible underlying mechanism
H Mokhtari, L Farahmand, K Yaserian, N Jalili, K Majidzadeh‐A
Journal of Cellular Physiology 234 (5), 6778-6782, 2019
The effect of mesenchymal stem cell-conditioned medium on proliferation and apoptosis of breast cancer cell line
L Farahmand, R Esmaeili, L Eini, K Majidzadeh-A
Journal of cancer research and therapeutics 14 (2), 341-344, 2018
The role of mucosal immunity and recombinant probiotics in SARS-CoV2 vaccine development
S Moradi-Kalbolandi, K Majidzadeh-A, MH Abdolvahab, N Jalili, ...
Probiotics and antimicrobial proteins, 1-15, 2021
Suppression of chronic inflammation with engineered nanomaterials delivering nuclear factor κB transcription factor decoy oligodeoxynucleotides
L Farahmand, B Darvishi, K Majidzadeh-A
Drug Delivery 24 (1), 1249-1261, 2017
Necroptosis triggered by ROS accumulation and Ca2+ overload, partly explains the inflammatory responses and anti-cancer effects associated with 1Hz, 100 mT ELF-MF in vivo
M Barati, MA Javidi, B Darvishi, SP Shariatpanahi, ZSM Moosavi, ...
Free Radical Biology and Medicine 169, 84-98, 2021
The system can't perform the operation now. Try again later.
Articles 1–20